ADC Therapeutics S.A. (ADCT) Social Stream
ADC THERAPEUTICS SA (ADCT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ADCT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 7 | $55 | $34 | $43.714 | $0.88 | 4867.5% |
| 2022-02-08 | 7 | $55 | $29 | $41.142 | $0.88 | 4575.23% |
| 2022-04-12 | 7 | $54 | $26 | $37.285 | $0.88 | 4136.93% |
| 2022-04-19 | 7 | $54 | $26 | $37.142 | $0.88 | 4120.68% |
| 2022-05-10 | 6 | $54 | $30 | $38 | $0.88 | 4218.18% |
| 2022-05-23 | 6 | $54 | $17 | $35.833 | $0.88 | 3971.93% |
| 2022-06-15 | 6 | $54 | $17 | $33 | $0.88 | 3650% |
| 2022-07-14 | 6 | $44 | $17 | $31.333 | $0.88 | 3460.57% |
| 2022-08-09 | 6 | $44 | $16 | $31.166 | $0.88 | 3441.59% |
| 2022-08-13 | 6 | $44 | $15 | $29 | $0.88 | 3195.45% |
| 2022-08-22 | 6 | $44 | $15 | $25 | $0.88 | 2740.91% |
| 2022-09-17 | 6 | $44 | $11 | $24 | $0.88 | 2627.27% |
| 2022-09-19 | 6 | $44 | $11 | $24.166 | $0.88 | 2646.14% |
| 2022-09-21 | 7 | $44 | $5 | $21.428 | $0.88 | 2335% |
| 2022-10-21 | 7 | $44 | $5 | $21.285 | $0.88 | 2318.75% |
| 2022-11-08 | 7 | $44 | $5 | $21.285 | $0.88 | 2318.75% |
| 2022-11-09 | 7 | $25 | $5 | $14.833 | $0.88 | 1585.57% |
| 2022-11-14 | 7 | $25 | $5 | $14.166 | $0.88 | 1509.77% |
| 2022-12-19 | 8 | $25 | $5 | $13.857 | $0.88 | 1474.66% |
| 2023-01-25 | 8 | $25 | $5 | $13.714 | $0.88 | 1458.41% |
| 2023-03-03 | 8 | $25 | $5 | $13.428 | $0.88 | 1425.91% |
| 2023-03-09 | 7 | $20 | $5 | $12.285 | $0.88 | 1296.02% |
| 2023-04-21 | 8 | $20 | $5 | $12.285 | $0.88 | 1296.02% |
| 2023-04-24 | 8 | $20 | $2 | $11.571 | $0.88 | 1214.89% |
| 2023-05-09 | 8 | $20 | $2 | $12.666 | $0.88 | 1339.32% |
| 2023-05-16 | 8 | $20 | $2 | $9.857 | $0.88 | 1020.11% |
| 2023-06-06 | 8 | $20 | $2 | $10.666 | $0.88 | 1112.05% |
| 2023-07-11 | 8 | $17 | $2 | $9.333 | $0.88 | 960.57% |
| 2023-08-09 | 8 | $17 | $2 | $8.333 | $0.88 | 846.93% |
| 2023-09-11 | 8 | $17 | $2 | $8.166 | $0.88 | 827.95% |
| 2023-09-19 | 8 | $17 | $2 | $7.833 | $0.88 | 790.11% |
The Trend in the Analyst Price Target
Over the past 132 days, ADCT's average price target has gone down $2.02.
Over the past 48 weeks, ADCT's average upside potential has been 386.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 8 | 25 | 5 | 13.428 | 5.05 | 165.9% |
| 2023-05-16 | 8 | 20 | 2 | 9.857 | 2.44 | 303.98% |
| 2023-06-20 | 8 | 17 | 2 | 9.333 | 2.28 | 309.34% |
| 2023-08-09 | 8 | 17 | 2 | 8.166 | 1.50 | 444.4% |
| 2023-09-01 | 8 | 17 | 2 | 8.166 | 1.22 | 569.34% |
ADCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 4 | 1 | 2 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
ADCT's average broker recommendation rating worsened by 0.71 over the prior 18 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ADC THERAPEUTICS SA's upside potential (average analyst target price relative to current price) is greater than 3534.44% of them.
- In the context of stocks in the mid market cap category, ADC THERAPEUTICS SA's variance in analysts' estimates is lower than -3161.17% of them.
- In terms of how ADC THERAPEUTICS SA fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 1007.71% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ADC THERAPEUTICS SA's number of analysts covering the stock is higher than 1626.34% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADC THERAPEUTICS SA are ROIV, LYEL, and AMLX.
View All Top Stocks by Price Target
Make investment decisions regarding ADCT using the data that counts. Try POWR Ratings for free.